Stealth BioTherapeutics Presents Data for Elamipretide on Cardiac Function in Barth Syndrome

Print Friendly, PDF & Email

New data from open-label extension portion of TAZPOWER study demonstrated improved cardiac function BOSTON, Oct. 17, 2019 /PRNewswire/ — Stealth BioTherapeutics ( MITO ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced the presentation of new […]